J. B. Chemicals & Pharmaceuticals Limited J. B. Chemicals & Pharmaceuticals Limited

J. B. Chemicals & Pharmaceuticals Limited

JBCHEPHARM

株式のランク #3899
J. B. Chemicals & Pharmaceuticals Limited, an enterprise founded in Mumbai,... J. B. Chemicals & Pharmaceuticals Limited, an enterprise founded in Mumbai, India, in 1976, specializes in the development, production, and global distribution of diverse pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients. Among its prominent product offerings are Cilnidipine, Ranitidine, and Metronidazole. Beyond its own brands, the company extends comprehensive contract manufacturing services, covering an extensive spectrum of dosage forms such as tablets, various lozenge types, injectables, gels, creams, ointments, liquid herbal syrups, and capsules. The firm further contributes to diagnostic medicine by supplying contrast agents for advanced imaging techniques like X-ray, MRI, and ultrasound. Its therapeutic expertise encompasses a broad range of medical fields, including gastroenterology, hypertension, diabetes, dermatology, nephrology, wound care, anti-infectives, and pharmacovigilance.
株価
$26.58
最終同期: 2026-07-23
時価総額
$4.24B
変化(1日)
0.00%
変化(1年)
38.40%
国
IN
取引 J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM)

カテゴリー

Healthcare
J. B. Chemicals & Pharmaceuticals Limited(JBCHEPHARM)のP/B比率
October 2026 時点のP/B比率 TTM: 9.27
J. B. Chemicals & Pharmaceuticals Limited の最新の財務報告および株価によると、現在のP/B比率(TTM)は 9.27 です。2024 年末時点でのP/B比率は 8.99 でした。
J. B. Chemicals & Pharmaceuticals Limited の P/B 比率の履歴(2005 ~ 2026)
各年末時点のP/B比率
年 P/B比率 変化
2026 (TTM) 9.27 29.34%
2025 7.17 -20.26%
2024 8.99 45.87%
2023 6.16 7.98%
2022 5.71 6.43%
2021 5.36 91.96%
2020 2.79 36.00%
2019 2.05 12.86%
2018 1.82 -15.48%
2017 2.15 11.29%
2016 1.93 13.81%
2015 1.70 63.33%
2014 1.04 64.51%
2013 0.63 18.87%
2012 0.53 -67.05%
2011 1.62 53.39%
2010 1.05 60.86%
2009 0.65 -29.39%
2008 0.93 -41.37%
2007 1.58 -43.38%
2006 2.79 19.52%
2005 2.34 0.00%